公司资料
Fresenius Medical Care Ventures 股价、新闻与催化剂
- 股票代码:
- FMS
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- Germany and listed in the U
股票表现
23.50 USD (-1.14%)
收盘价
最后更新: 2026年8月17日
11B USD
市值
股价为何变动
As of Aug 17, 2026, FMS closed down 1.14% at $23.50. No new same-company headline was identified in the current news window.
公司概览
业务概览
Fresenius Medical Care is a global dialysis and kidney-care company focused on renal services, dialysis products, and related healthcare infrastructure. Its business is built around treating chronic kidney disease at scale.
所在地与行业分类
Headquartered in Germany and listed in the U.S. as an ADR, Fresenius Medical Care has a global operating footprint. It sits in healthcare services and dialysis, not biotechnology.
商业模式特征
The company generates revenue through dialysis treatments, care services, and medical products used in renal care. Investors focus on reimbursement, patient volume, treatment economics, and operational efficiency.
生物医药行业定位
Fresenius Medical Care is not a biotech name, but it matters to healthcare investors because it sits in a critical chronic-care segment. Its stock is driven by utilization and reimbursement rather than trial data.
未来催化剂
- Fresenius Medical Care’s catalysts are dialysis margin recovery, care-delivery efficiency, and any update on the turnaround plan. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。